TotalMarketCap

Xenetic Biosciences

XBIONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.429 M

$1.89 -5.97%

Close of 6 Nov 2026

As of 6 Nov 2026, Xenetic Biosciences (XBIO) has a market capitalization of $4.43M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.98M

#3348 by revenue

Earnings

-$2.68M

Loss-making

Shares outstanding

2,343,181

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #454Can-Fite BioPharmaCANF$4.85M
  2. #455Skye BioscienceSKYE$4.65M
  3. #456Xenetic BiosciencesXBIO$4.43M
  4. #457AzitraAZTR$4.43M
  5. #458Xtl BiopharmaceuticalsXTLB$4.22M

What if Xenetic Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$12,050,659

Per share 6,376,010× higher

Bitcoin $1.53T

$652,040.16

Per share 344,995× higher

Apple $5.02T

$2,140,587

Per share 1,132,586× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Xenetic Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.